It has been reported that miR-26a is able to inhibit the expression of HMGA2 in gallbladder cancer and non-small cell lung cancer, and upregulate PTEN expression in gastric cancer37–39. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.